All Practice-based pharmacist articles – Page 3
-
SIGN guidelineSIGN epilepsies in children and young people
An easy-to-read summary of SIGN’s recommendations on the management of epilepsy in children and young people in primary care. Includes recommendations, and good practice and information points
-
PHE/DH/DWP guideline
PHE management of staff exposure to COVID-19
This summary provides guidance on the management of staff according to COVID-19 exposures, symptoms, and test results
-
News
NHS England to routinely offer novel cholesterol-lowering jab
The twice-yearly inclisiran injection, which will be available through GP surgeries across England, could save 30,000 lives over the next 10 years
-
News
Renal decline slower with rivaroxaban than warfarin in patients with atrial fibrillation
Patients with atrial fibrillation report fewer adverse renal outcomes and a slower decline in renal function on rivaroxaban compared with warfarin
-
News
Additional mental health services rolled out to veterans
Armed forces veterans will benefit from £2.7 million boost to mental health services through Op COURAGE
-
News
Blood clot risks ‘lower with COVID vaccines than from infection’
A study has found the risk of haematological and vascular adverse events following a first dose of two COVID vaccines was significantly lower than from infection with SARS-CoV-2
-
News
NICE publishes guideline on the healthcare experiences of babies, children, and young people
New NICE guidance advises empowering children and young people to take an active role in their healthcare
-
News
Pfizer COVID-19 jab side effects mild or moderate in at-risk 12–15 year olds: study
According to the findings of a small study, the Pfizer/BioNTech vaccine causes mostly mild or moderate side effects in 12–15-year old children considered vulnerable to COVID-19 infection
-
News
New insight into COVID-19 vaccine effects for immune-vulnerable patients
Some immunosuppressed patients mount an almost undetectable antibody response after two jabs, and may benefit from a booster COVID-19 vaccine
-
News
COVID antibody surveillance programme announced
An antibody surveillance programme is to be launched across the UK for people who test positive for COVID-19
-
News
New guidance sets out plan for integrated care boards
The interim guidance from NHS England lays out how NHS leaders and organisations will operate with their partners in integrated care systems from April 2022
-
News
New President of the RCGP: seeking solutions to the GP crisis
Professor Dame Clare Gerada, who takes up the presidency in November, calls for increased support for GPs exhausted by work during the pandemic
-
News
New guidance on obstructive breathing disorders published by NICE
NICE guideline 202 covers investigation and management of obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s
-
PHE/DH/DWP guideline
PHE influenza immunisation policy
This summary provides comprehensive guidance about flu immunisation for public health professionals
-
News
More cash for Better Care Fund to support health and care integration
Over £6.9 billion has been committed to the fund to help people in England stay and home and live independently, and to help local recovery from the COVID-19 pandemic
-
News
Delta variant of SARS-CoV-2 ‘still transmissible for double jabbed’
The Delta variant blunts the efficacy of the Pfizer and AstraZeneca COVID-19 vaccines and may remain transmissible by doubly vaccinated individuals, according to preliminary research
-
PHE/DH/DWP guideline
PHE COVID-19 infection prevention and control guidance
Summary of the latest UK guidance on infection prevention and control measures for COVID-19
-
News
First monoclonal antibody treatment for COVID-19 approved by MHRA
The first monoclonal antibody combination product for preventing and treating COVID-19 has been approved for use in the UK
-
News
Diet and exercise linked to risk of cognitive decline
Cognitive decline and dementia can be influenced by levels of diet and exercise up to 12 years before the onset of symptoms
-
News
Combined ibuprofen and paracetamol medicine to become available
A new medicine containing both ibuprofen and paracetamol has been approved for general sale without the need to visit a pharmacy
